CHANGES IN PROOPIOMELANOCORTIN AND PRE-PROENKEPHALIN MESSENGER-RNA LEVELS IN THE OVINE BRAIN DURING PREGNANCY, PARTURITION AND LACTATION AND IN RESPONSE TO ESTROGEN AND PROGESTERONE

In the female sheep opioids act centrally to influence both oxytocin release and maternal behaviour. We have used in situ hybridization histochemistry to investigate the changes in mRNA expression of the two opioid precursor genes, pro-opiomelanocortin (POMC) and pre-proenkephalin (PPE), in discrete hypothalamic nuclei as a function of pregnancy, parturition and lactation and following treatment with oestrogen and progesterone. Quantitative in situ hybridization histochemistry demonstrated that POMC mRNA expression in the arcuate nucleus (ARC) decreased at parturition and increased during lactation compared to late pregnant and ovariectomized animals. Oestradiol and progesterone treatments increased POMC mRNA expression compared to ovariectomized controls. Pre-proenkephalin mRNA expression was quantified in three discrete hypothalamic nuclei, the ventromedial nucleus (VMN), the paraventricular nucleus (PVN) and the suprachiasmatic nucleus (SCN). In the VMN, PPE mRNA expression increased during lactation compared to late pregnancy and parturition. Expression levels during late pregnancy and parturition were decreased compared to ovariectomized animals. Oestradiol increased, and progesterone decreased, PPE mRNA levels compared to ovariectomized controls. Combined progesterone followed by oestrogen treatment produced significant increases in PPE mRNA expression. In the PVN, PPE expression increased at parturition compared to late pregnant, lactating and ovariectomized animals. Expression levels in late pregnant animals were decreased compared to lactating or ovariectomized ones. However, sex steroid treatment produced no changes in PPE expression in the PVN. No changes were observed in PPE mRNA expression in the SCN in response to any of the experimental conditions. This data shows that both POMC and PPE mRNA levels are altered in the sheep brain during pregnancy, parturition and lactation and in response to sex steroids, although the direction of the changes is not always the same and in the case of PPE only the VMN and PVN are affected. Levels of gene expression found following exogenous steroid treatment do not precisely mirror those found during pregnancy, parturition and lactation and this suggests that factors other than changing sex steroids levels are involved. In the context of maternal behaviour it is interesting to note that PPE mRNA expression increases at parturition in the PVN when oxytocin mRNA expression levels are also increased.